BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 26229456)

  • 1. Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.
    Mitsiki E; Bania E; Varounis C; Gourgoulianis KI; Alexopoulos EC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1371-82. PubMed ID: 26229456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
    Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and risk factors of COPD exacerbations and hospitalizations: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).
    Alexopoulos EC; Malli F; Mitsiki E; Bania EG; Varounis C; Gourgoulianis KI
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2665-74. PubMed ID: 26715845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missed diagnosis and overtreatment of COPD among smoking primary care population in Central Greece: old problems persist.
    Stafyla E; Kotsiou OS; Deskata K; Gourgoulianis KI
    Int J Chron Obstruct Pulmon Dis; 2018; 13():487-498. PubMed ID: 29440886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex discrepancies in COPD patients and burden of the disease in females: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study).
    Papaioannou AI; Bania E; Alexopoulos EC; Mitsiki E; Malli F; Gourgoulianis KI
    Int J Chron Obstruct Pulmon Dis; 2014; 9():203-13. PubMed ID: 24600217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study.
    Ivanov Y; Nikolaev I; Nemeth I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():653-663. PubMed ID: 29503539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis.
    Fernández-Villar A; López-Campos JL; Represas Represas C; Marín Barrera L; Leiro Fernández V; López Ramírez C; Casamor R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():961-7. PubMed ID: 26028969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
    Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COPD characteristics and socioeconomic burden in Hellenic correctional institutions.
    Bania EG; Daniil Z; Hatzoglou C; Alexopoulos EC; Mitsiki E; Gourgoulianis KI
    Int J Chron Obstruct Pulmon Dis; 2016; 11():341-9. PubMed ID: 26929618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.
    Ding B; Small M; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1527-1537. PubMed ID: 28579771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN; Yu WC; Wong CK; Lam MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients.
    Kim J; Kim K; Kim Y; Yoo KH; Lee CK; Yoon HK; Kim YS; Park YB; Lee JH; Oh YM; Lee SD; Lee SW
    Respir Med; 2014 Jan; 108(1):153-61. PubMed ID: 23993445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
    Ágh T; Inotai A; Mészáros Á
    Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
    Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project.
    Viejo-Bañuelos JL; Pueyo-Bastida A; Fueyo-Rodríguez A
    Respir Med; 2006 Dec; 100(12):2137-43. PubMed ID: 16831541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Function Abnormalities in Smokers with Ischemic Heart Disease.
    Franssen FM; Soriano JB; Roche N; Bloomfield PH; Brusselle G; Fabbri LM; García-Rio F; Kearney MT; Kwon N; Lundbäck B; Rabe KF; Raillard A; Muellerova H; Cockcroft JR
    Am J Respir Crit Care Med; 2016 Sep; 194(5):568-76. PubMed ID: 27442601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers.
    Rasmussen T; Køber L; Pedersen JH; Dirksen A; Thomsen LH; Stender S; Brodersen J; Groen J; Ashraf H; Kofoed KF
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1159-66. PubMed ID: 23639550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.